| Topics: 
 ◾Approach to the Elderly with Borderline Metabolic Conditions
 ◾Arterial Properties, Central Blood Pressure and Augmentation Index in the Continuum of Prehypertension and Hypertension
 ◾Arterial Properties, Evaluation and Treatment in Borderline Conditions
 ◾Assessment of Global Cardiovascular Risk Factors in Borderline Conditions
 ◾Benefits of Achieving Optimal Risk Factors Level – When, How and with What?
 ◾Biomarkers of Borderline Conditions and Preclinical Disease
 ◾Borderline Cardiovascular Risk Factors - Morbidity and Mortality
 ◾Children and Adolescents and Cardiovascular Risk Factors- Diagnosis, Estimation of Risk and Treatment
 ◾Complications of Prehypertension, Hypertension and Cardiometabolic Syndrome: the Heart, the Brain, the Kidney and the Extremities
 ◾Cumulative Effects of Multiple Borderline Cardiometabolic Risk Factors
 ◾Diabetes, Prevention, Mechanisms and Treatment of end Organ Damage
 ◾Humoral Factors in Prehypertension and Cardiometabolic Syndrome
 ◾Hypertension, Mechanisms and Therapeutic Approach
 ◾Management of Dyslipidemia, Mechanisms and Novel Therapeutic Regimens
 ◾Metabolic Syndrome and Borderline Metabolic Conditions
 ◾Natural History of Prehypertension, Hypertension and End Organ Damage
 ◾Obesity, Mechanisms and Therapy
 ◾Prediabetes – Mechanism, Diagnosis, and Management
 ◾Prehypertension and Metabolic Syndrome in Different Populations – Epidemiology
 ◾Prehypertension, Cause and Results
 ◾Prehypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach
 ◾Prehypertension – Progression of Risk and Diagnosis of Disease
 ◾Prehypertension- Mechanism, Diagnosis and Management
 ◾Prevention and Regression of End Organ Damage in Prehypertension
 ◾The Heart, the Brain and the Kidney in Prehypertension and Cardiometabolic Syndrome
 ◾Total Cardiovascular Risk Evaluation and Management
 |